BNOX

Bionomics

0.4048 USD
+0.0248
6.53%
At close Nov 8, 4:00 PM EST
After hours
0.3894
-0.0154
3.80%
1 day
6.53%
5 days
102.40%
1 month
42.54%
3 months
-31.97%
6 months
-57.89%
Year to date
-70.01%
1 year
-83.74%
5 years
-97.25%
 

About: Bionomics Ltd is a clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.

Employees: 24

0
Funds holding %
of 6,759 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

43% more capital invested

Capital invested by funds: $1.22M [Q1] → $1.74M (+$520K) [Q2]

30% more funds holding

Funds holding: 10 [Q1] → 13 (+3) [Q2]

0.06% more ownership

Funds ownership: 0.06% [Q1] → 0.12% (+0.06%) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for BNOX.

Financial journalist opinion

Based on 4 articles about BNOX published over the past 30 days

Charts implemented using Lightweight Charts™